1. FRI0046 Characterization of nitrotyrosine as a clinical biomarker for arthritis and joint injury. (23rd January 2014) Authors: Misko, T.P.; Radabaugh, M.R.; Highkin, M.; Abrams, M.; Listello, J.; Friese, O.; Gallavan, R.; Bramson, C.; Hellio le Graverand-Gastineau, M.P.; Lohmander, L.S.; Roman, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: CLINICAL OUTCOMES AND MOLECULAR PROFILE OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA SUPPORT ITS CONSIDERATION AS THE FIRST STEP IN THE PROLIFERATIVE CONTINUUM OF CHRONIC MYELOMONOCYTIC LEUKEMIA. (September 2021) Authors: Arenillas, L.; Roman, D.; Asensi, M.T.; Garcia-Gisbert, N.; Rodriguez, J.J.; Merchan, B.; Garcia, S.; Bellosillo, B.; Fernandez, M.C.; Florensa, L.; Ferrer, A.; Calvo, X. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: PREDICTIVE FACTORS OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA (OM-CMML) EVOLUTION TO OVERT CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML). (September 2021) Authors: Roman, D.; Arenillas, L.; Asensi, M.T.; Garcia-Gisbert, N.; Rodriguez, J.J.; Merchan, B.; Garcia, S.; Bellosillo, B.; Fernandez, M.C.; Florensa, L.; Ferrer, A.; Calvo, X. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗